Skip to main navigation

BioAtla, Inc logo

preloader
BioAtla, Inc logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Events and Presentations

Presentations

2024 Annual Shareholder Meeting 25.5 MB
Corporate Presentation – March 2026 5.1 MB

Past Events

5/14/24 at 4:30 PM EDT
BioAtla First Quarter 2024 Financial Results and Business Highlights Conference Call
Click here for webcast
5/13/24 at 9:30 AM EDT
BioAtla at the Citizens JMP Life Sciences Conference
Click here for webcast
3/26/24 at 4:30 PM EDT
BioAtla Fourth Quarter and Full Year 2023 Earnings Call
Click here for webcast
1/11/24
BioAtla at 42nd Annual J.P. Morgan Healthcare Conference
Click here for webcast
12/18/23
Dec 18 JPM Biotech Call Series
Click Here for replay options
12/13/23 at 10:00 AM EST
CAB-CTLA-4 R&D Day Webcast - December 13, 2023
Click here for webcast
12/6/23 at 1:00 PM EST
BioAtla Fireside Chat Webcast – The JMP Securities Hematology and Oncology Summit
Click here for webcast
12/4/23 at 11:00 AM EST
Webcast - BA3011 in NSCLC KOL Event
Click here for webcast
BA3011 in NSCLC KOL Event Presentation 2.4 MB
11/15/23 at 12:00 PM GMT
BioAtla Fireside Chat - Jefferies London Healthcare Conference 2023
Click here for webcast
11/7/23 at 4:30 PM EST
BioAtla Third Quarter 2023 Financial Results and Business Highlights Conference Call
Click here for webcast

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Next page next ›
  • Last page last »
logo-footer

BioAtla® is a leading San Diego-based biopharmaceutical company developing safer and more effective drugs for cancer. Its Conditionally Active Biologics™ (CAB) platform exploits the unique microenvironment of diseased tissue to more effectively target cancer.

BIOATLA®

  • Technology
  • CAB Portfolio
  • Appendix

COMPANY

  • About
  • Team
  • Careers
  • News

LEGAL

  • Privacy Policy
  • Site Map
  • Expanded Access

GET IN TOUCH

  • Contact
  • Corporate Headquarters +1 858-558-0708

FOLLOW US

  • LinkedIn
  • Copyright © 2026 BioAtla®, Inc. All rights reserved